Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.4.0.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 3 Months Ended
Mar. 31, 2016
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Schedule of Concentration of Revenue and Geographic Area

 

For the Three Months Ended March 31, 2016

 

For the Three Months Ended March 31, 2015

Licensor

 

License
Amount

 

% of Revenue

 

Licensor

 

License
Amount

 

% of Revenue

Signal IP, Inc.

 

$
1,900,000 

 
92%

 

Vantage Point Technology, Inc.

 

$

 
2,750,000 

 
67%

Signal IP, Inc.

 

$
15,000 

 
1%

 

Signal IP, Inc.

 

$

 
275,000 

 
7%

 

 

 

 

 

 

Sarif Biomedical, LLC

 

$

 
225,000 

 
6%

 

 

 

 

 

 

TLIF, LLC

 

$

 
220,000 

 
5%

 

 

 

 

 

 

Vantage Point Technology, Inc.

 

$

 
80,000 

 
2%

% of Total Revenues

 
93%

 

% of Total Revenues
87%

 

Schedule of computation of basic and diluted loss per share

 

 

 

For the Three Months
Ended March 31, 2016

 

For the Three Months
Ended March 31, 2015

 

 

 

 

 

 

 

Net loss

 
(3,893,413)

 
(4,781,571)

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

Weighted Average Common Shares - Basic

 
14,967,141

 
13,868,811 

 

Weighted Average Common Shares - Diluted

 
14,967,141

 
13,868,811 

 

 

 

 

 

 

 

Earnings (Loss) per common share:

 

 

 

 

 

Income (Loss) - Basic

 

$
(0.26)

 

$
(0.34)

 

Income (Loss) - Diluted

 

$
(0.26)

 

$
(0.34)